BioDelivery Sciences International Inc (BDSI)

Business: BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally.

IPO Date: 25-Jul-2002

CEO & Director: Mr. Jeffrey Allen Bailey

Pres & Chief Commercial Officer: Mr. Scott M. Plesha

Listing: NASDAQ: BDSI

Country: United States

Headquarters: Raleigh, NC

Website: https://www.bdsi.com

Market cap: $577.05 Mln

Revenue (TTM): $84.17 Mln

Earnings (TTM): $84.86 Mln

Cash: $114.31 Mln

Total Debt: $4.62 Mln

Insider's Holding: 7.58%

Liquidity: Low

52 Week range: $2.50 - 5.62

Shares outstanding: 103,229,000

10 Years Aggregate:

• CFO: $-113.94 Mln
• EBITDA: $-124.69 Mln
• Net Profit: $-148.09 Mln